Tree Nut Allergy Clinical Trial
Official title:
Walnut Oral Immunotherapy for Tree Nut Allergy
The purpose of this study is to determine if walnut oral immunotherapy can be used in participants allergic to tree nuts to reduce tree nut allergy and induce changes in the participant's immune system.
Randomized, placebo controlled, Phase 1-2 study conducted at Arkansas Children's Hospital Research Institute (ACHRI) in tree nut allergic participants, ages 6-45 years with randomization following a 2:1 (active:placebo) format. The overall objectives were to evaluate the efficacy of walnut oral immunotherapy (WOIT) for induction of desensitization to walnut (secondary outcome) and a test tree nut (primary outcome) when compared to placebo after 38 weeks of treatment as assessed by double-blind, placebo-controlled food challenges (DBPCFC) to walnut and a test tree nut in tree nut allergic participants (defined by allergic reaction to </= 2 grams of walnut and test tree nut proteins during DBPCFC at study entry). Placebo participants were crossed-over to active therapy after unblinding at week 38. Participants were followed long-term (up to 6 years) on open-label WOIT treatment and assessed at yearly intervals based on pre-specified criteria for clinical outcomes of desensitization to walnut and a test tree nut (defined as safely consuming 5 grams of walnut and test tree nut protein during DBPCFC while on daily WOIT) and sustained unresponsiveness to walnut and a test tree nut (defined as safely consuming 5 grams of walnut and test tree nut protein during DBPCFC and 10 grams during an open feeding while off therapy for 4-6 weeks). Secondary outcomes were evaluated including safety and immune mechanistic parameters. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06038019 -
Thresholds In Food Allergy evaluaTion And predictioN
|
||
| Not yet recruiting |
NCT05521711 -
TRADE Trial - Tree Nut Immunotherapy Route Development and Evaluation
|
N/A | |
| Active, not recruiting |
NCT04151069 -
Re-Introducing Nuts in Allergic Patients
|
||
| Completed |
NCT02961452 -
Phenotypical Characterization of Peanut Allergic Children
|
N/A | |
| Active, not recruiting |
NCT03532360 -
Peanut and Tree Nut Desensitization
|
N/A | |
| Recruiting |
NCT05662800 -
Development of Peanut, Sesame, and Tree Nut Allergy in Polish Children at High Risk of Food Allergy
|
||
| Terminated |
NCT03680066 -
Study to Assess Tolerance of Traces in Peanut/Tree Nut Allergic Children.
|
N/A |